US Stock MarketDetailed Quotes

MXCT MaxCyte

Watchlist

4.240
+0.100+2.42%

Close Dec 20 16:00 ET

4.240
0.0000.00%

Post 20:01 ET

447.25MMarket Cap-12.47P/E (TTM)

MaxCyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MaxCyte Q3 2024 Earnings Date

Currency：USDNov 6, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	7.36M	8.16M	+799.67K
Beat Est.	-8.00%	+2.00%	+10.86%
EPS	-0.12	-0.11	+0.01
Beat Est.	-12.10%	--	+10.71%

Analyst Rating

Strong Buy

Dec 20, 2024

MaxCyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 9.329M	--
--	2024/Q4	-- / 7.667M	--
Nov 6, 2024	2024/Q3	8.164M / 7.364M	--
Aug 6, 2024	2024/Q2	10.429M / 7.933M	--
May 7, 2024	2024/Q1	11.342M / 7.441M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 9.329M--

--2024/Q4-- / 7.667M--

Nov 6, 20242024/Q38.164M / 7.364M--

Aug 6, 20242024/Q210.429M / 7.933M--

May 7, 20242024/Q111.342M / 7.441M--

Unlock Free Earnings Estimates

Open Account

MaxCyte Earnings Reports

MaxCyte | 10-Q: Quarterly report

Nov 6 16:57 ET

MaxCyte | 8-K: MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

Nov 6 16:27 ET

MaxCyte | 10-Q: Quarterly report

Aug 6 16:59 ET

MaxCyte | 8-K: MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance

Aug 6 16:21 ET

Trending US Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 20, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data